Table 2.
National Estimates of Emergency Department Visits for Dietary Supplement Adverse Events by Product Category, Excluding Unsupervised Child Ingestions—United States, 2004–2013*
Product Category† | Emergency Department Visits for Dietary Supplement Adverse Events | |
---|---|---|
National Estimate | ||
% | 95% Confidence Interval | |
Herbals/Complementary Nutritionals | 65.9 | 63.2 – 68.5 |
Weight Loss | 25.5 | 23.1 – 27.9 |
Energy | 10.0 | 8.0 – 11.9 |
Sexual Enhancement | 3.4 | 2.4 – 4.3 |
Cardiovascular Health | 3.1 | 2.3 – 3.9 |
Sleep, Sedation or Anxiolysis | 2.9 | 2.1 – 3.6 |
Laxative | 2.5 | 1.8 – 3.3 |
Bodybuilding | 2.2 | 1.1 – 3.2 |
Immunity Infection/Cold | 2.2 | 1.5 – 2.9 |
Pain/Arthritis Relief | 1.7 | 1.2 – 2.3 |
Detoxification or Cleansing | 1.4 | 0.7 – 2.0 |
Skin or Hair Health | 1.0 | 0.6 – 1.4 |
Microbial Additive | 0.8‡ | 0.4 – 1.3 |
Other Specified Products | 4.8 | 3.7 – 5.9 |
Unspecified Products | 4.4 | 3.3 – 5.4 |
Micronutrients | 31.8 | 29.2 – 34.3 |
Multivitamins or Unspecified Vitamins | 16.8 | 15.1–18.5 |
Iron | 4.7 | 3.4 – 6.1 |
Calcium | 3.4 | 2.5 – 4.3 |
Potassium | 2.0 | 1.2 – 2.7 |
Other Single-ingredient Vitamins or Minerals | 4.9 | 3.6 – 6.2 |
>1 Supplement Product§ | 2.4 | 1.4 – 3.3 |
Total | 100.0 | N/A |
National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance project, CDC.
For definitions and specific products please see Tables S1 and S2 in Supplementary Appendix.
National estimate may be unstable (based on <20 cases).
Of 71 cases implicating two supplement products, 45 cases implicated two herbal/complementary nutritional products, 6 cases implicated two micronutrient products, and 20 cases implicated both a micronutrient and herbal/complementary nutritional product.